Bookmark and Share

Compound Summary for: CID 300471


Also known as: STA-4783; 488832-69-5; STA 4783; UNII-6UK191M53P; N'1,N'3-dimethyl-N'1,N'3-bis(phenylcarbonothioyl)propanedihydrazide; STA4783
Molecular Formula: C19H20N4O2S2   Molecular Weight: 400.5177   InChIKey: BKJIXTWSNXCKJH-UHFFFAOYSA-N
Elesclomol is a novel, injectable, drug candidate that kills cancer cells by elevating oxidative stress levels beyond a breaking point, triggering programmed cell death. In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal additional toxicity, at moderate doses. It is being developed by Synta Pharmaceuticals.   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Biological Test Results
Chemical and Physical Properties
_ _